Global Decline in Chronic Disease Mortality Shows Signs of Slowing Progress

A new study reveals that while deaths from chronic diseases are declining worldwide, the rate of improvement is slowing, emphasizing the need for stronger global health efforts. Read more about the latest findings and implications for future strategies.
Recent research published in The Lancet indicates that while mortality rates from chronic diseases such as cancer, cardiovascular conditions, diabetes, and neurological disorders have decreased in nearly 80% of countries worldwide over the past decade, the pace of this decline is gradually slowing down. The comprehensive analysis, led by experts from Imperial College London, highlights that in the period from 2010 to 2019, many nations experienced a deceleration in the reduction of death rates related to non-communicable diseases (NCDs). Notably, high-income countries—including those in Europe, North America, Australasia, and the Pacific—showed a significant slowdown, with the United States marked as one of the poorer performers among developed nations. These findings come ahead of the Fourth High-level Meeting of the UN General Assembly, underscoring an urgent need for enhanced investments and strategic approaches to address chronic diseases more effectively. Despite the global decrease, the trend signals a critical juncture requiring intensified efforts to sustain and accelerate progress in reducing preventable mortality caused by non-communicable diseases.
Stay Updated with Mia's Feed
Get the latest health & wellness insights delivered straight to your inbox.
Related Articles
The Influence of Urban Environment on the Link Between ADHD and Obesity
Emerging research highlights that the link between ADHD and obesity varies with urban living conditions, emphasizing the importance of city environment and health services in managing both conditions.
Genetic Mutation Influences Iron Deficiency in Crohn's Disease Patients
A groundbreaking study reveals how genetic mutations in PTPN2 impair iron absorption, leading to anemia in Crohn's disease patients, paving the way for personalized therapies.



